Simvastatin and the Rho-Kinase Inhibitor Y-27632 Prevent Myofibroblast Transformation in Peyronie’s Disease-Derived Fibroblasts via Inhibition of YAP/TAZ Nuclear Translocation
European Urology, Supplements - Netherlands
doi 10.1016/s1569-9056(19)30897-8
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2019
Authors
Publisher
Elsevier BV